CD47 and acute lymphoblastic leukemia: Indeed, PKBH1 has been shown to induce ICD in T-ALL leukemia cell lines through the expression of CALR on the cell surface and by releasing HSPs as well as HMGB1, shedding light on the therapeutic potential of CD47 agonist peptides in the treatment of ALL (Table 4) [146].